DK0776201T3 - Behandling af angst - Google Patents

Behandling af angst

Info

Publication number
DK0776201T3
DK0776201T3 DK95930169T DK95930169T DK0776201T3 DK 0776201 T3 DK0776201 T3 DK 0776201T3 DK 95930169 T DK95930169 T DK 95930169T DK 95930169 T DK95930169 T DK 95930169T DK 0776201 T3 DK0776201 T3 DK 0776201T3
Authority
DK
Denmark
Prior art keywords
anxiety
treatment
agonist
acts
provides
Prior art date
Application number
DK95930169T
Other languages
English (en)
Inventor
David Reed Helton
Mary Jeanne Kallman
James Allen Monn
Darryle Darwin Schoepp
Joseph Patrick Tizzano
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0776201T3 publication Critical patent/DK0776201T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/38Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/18All rings being cycloaliphatic the ring system containing six carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Photolithography (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
DK95930169T 1994-08-12 1995-08-14 Behandling af angst DK0776201T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28995794A 1994-08-12 1994-08-12
US33734994A 1994-11-10 1994-11-10
US49671095A 1995-06-29 1995-06-29
PCT/US1995/010318 WO1996004901A1 (en) 1994-08-12 1995-08-14 Composition and method for treating anxiety

Publications (1)

Publication Number Publication Date
DK0776201T3 true DK0776201T3 (da) 2001-11-26

Family

ID=27403950

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95930169T DK0776201T3 (da) 1994-08-12 1995-08-14 Behandling af angst

Country Status (11)

Country Link
US (1) US5882671A (da)
EP (1) EP0776201B1 (da)
JP (1) JP3614435B2 (da)
AT (1) ATE206915T1 (da)
AU (1) AU3364995A (da)
CA (1) CA2195782A1 (da)
DE (1) DE69523324T2 (da)
DK (1) DK0776201T3 (da)
ES (1) ES2162936T3 (da)
PT (1) PT776201E (da)
WO (1) WO1996004901A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA969485B (en) * 1995-11-16 1998-05-12 Lilly Co Eli Excitatory amino acid receptor antagonists.
US5688826A (en) * 1995-11-16 1997-11-18 Eli Lilly And Company Excitatory amino acid derivatives
GB9605429D0 (en) * 1995-11-16 1996-05-15 Lilly Co Eli Excitatory amino acid receptor antagonists
US5912248A (en) * 1995-11-16 1999-06-15 Eli Lilly And Company Excitatory amino acid receptor antagonists
BR9611521A (pt) * 1995-11-16 1999-06-29 Lilly Co Eli Antagonistas de receptor de aminoácido excitador
CN1202167A (zh) * 1995-11-16 1998-12-16 伊莱利利公司 兴奋性的氨基酸衍生物
JP2001511131A (ja) * 1997-01-29 2001-08-07 イーライ・リリー・アンド・カンパニー 月経前不快障害の処置
ZA983930B (en) * 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
US6982361B1 (en) * 2000-02-25 2006-01-03 The Regents Of The University Of California Method of screening a compound for anxiolytic activity in an Apolipoprotein e knockout animal
NZ526050A (en) * 2001-01-11 2005-03-24 Lilly Co Eli Prodrugs of excitatory amino acids
US7038077B2 (en) * 2001-01-11 2006-05-02 Eli Lilly And Company Prodrugs of excitatory amino acids
US7456221B2 (en) * 2001-12-21 2008-11-25 Eli Lilly And Company Prodrugs of excitatory amino acids
US20040116489A1 (en) * 2002-02-12 2004-06-17 Massey Steven Marc Synthetic excitatory amino acids
US20050192273A1 (en) * 2002-04-03 2005-09-01 Johnson Bryan G. Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
KR20200035035A (ko) 2017-07-31 2020-04-01 노파르티스 아게 코카인 사용 감소 또는 코카인 사용 재발 예방에 있어서 마보글루란트의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325368D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds
US5750566A (en) * 1994-08-12 1998-05-12 Eli Lilly And Company Synthetic excitatory amino acids

Also Published As

Publication number Publication date
DE69523324D1 (de) 2001-11-22
HK1013958A1 (en) 1999-09-17
CA2195782A1 (en) 1996-02-22
DE69523324T2 (de) 2002-07-04
ATE206915T1 (de) 2001-11-15
PT776201E (pt) 2002-03-28
AU3364995A (en) 1996-03-07
US5882671A (en) 1999-03-16
EP0776201B1 (en) 2001-10-17
EP0776201A4 (en) 1999-07-07
JPH11507008A (ja) 1999-06-22
EP0776201A1 (en) 1997-06-04
JP3614435B2 (ja) 2005-01-26
ES2162936T3 (es) 2002-01-16
WO1996004901A1 (en) 1996-02-22

Similar Documents

Publication Publication Date Title
DK0776201T3 (da) Behandling af angst
DK0867178T3 (da) Non-allosteriske GABA A agonister til behandling af søvnforstyrrelser
DE69732868D1 (de) Mittel gegen Juckreiz
IS5085A (is) Nefholssamsetningar til meðhöndlunar á kynferðistruflunum
DK0901374T3 (da) Tetrahydropteridiner og pyridylpiperaziner til behandling af neurologiske forstyrrelser
ATE460204T1 (de) Gerät zur regelung des herzzeitvolumens
CY1107005T1 (el) Ετεροπολυκυκλικες ενωσεις και οι χρησεις τους ως ανταγωνιστες των μεταβοτροπικων υποδοχέων του γλουταμικου
NO20020837L (no) Fremgangsmåte for å identifisere et stoffs egenskaper hensyn til humane prostaglandin D-reseptorer
FR2727956B1 (fr) Generateur d'ozone, ensemble etablissant un entrefer, et ensemble d'uniformisation pour generateur d'ozone
DK1007053T3 (da) Behandling af smerte
ES2194960T3 (es) N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
EA200000349A1 (ru) Способ лечения оппозиционного расстройства
DK1482973T3 (da) Fremgangsmåde til modulering af CD200-receptorer
DE69619656D1 (de) Vorrichtung zur regulierung einer mechanischen spannung
DK0452074T3 (da) Ergolin-8-carboxamider, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende sådanne forbindelser
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
ES2057910T3 (es) Procedimiento y dispositivo para la obtencion de caseina beta.
IT1279993B1 (it) Metodo e macchina per la realizzazione contemporanea di piu' bachi di sigaretta
DK0819113T3 (da) Benzamider til behandling af neurodegenerative forstyrrelser
BR9608250A (pt) Aparelho e processo para aumentar a estabilidade de uma saida de um dispositivo oscilador dispositivo oscilador e processo para realimentar o mesmo
DK1385993T3 (da) Fremgangsmåde til detektering og behandling af tuberøs sclerose kompleksrelaterede lidelser
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
BR0206918A (pt) Uso de iloperidona
IT1279994B1 (it) Metodo e macchina per la realizzazione contemporanea di piu' bachi di sigaretta